Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice - PubMed (original) (raw)
. 2005 Dec;28(12):2258-62.
doi: 10.1248/bpb.28.2258.
Affiliations
- PMID: 16327161
- DOI: 10.1248/bpb.28.2258
Free article
Antiviral activity of the marine alga Symphyocladia latiuscula against herpes simplex virus (HSV-1) in vitro and its therapeutic efficacy against HSV-1 infection in mice
Hye-Jin Park et al. Biol Pharm Bull. 2005 Dec.
Free article
Abstract
The antiviral activities of extracts from 5 species of marine algae collected at Haeundae (Pusan, Korea), were examined using plaque reduction assays. Although the activity of a methanol (MeOH) extract of Sargassum ringoldianum (Sargassaceae) was the most potent against several types of viruses, it was also cytotoxic. A MeOH extract of Symphyocladia latiuscula (Rhodomelaceae) and its fractions exhibited antiviral activities against acyclovir (ACV) and phosphonoacetic acid (PAA)-resistant (AP(r)) herpes simplex type 1 (HSV-1), thymidine kinase (TK(-)) deficient HSV-1 and wild type HSV-1 in vitro without cytotoxicity. The major component, 2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether (TDB) of a CH(2)Cl(2)-soluble fraction was active against wild type HSV-1, as well as AP(r) HSV-1 and TK(-) HSV-1 (IC(50) values of 5.48, 4.81 and 23.3 microg/ml, respectively). The therapeutic effectiveness of the MeOH extract and TDB from S. latiuscula was further examined in BALB/c mice that were cutaneously infected with HSV-1 strain 7401H. Three daily oral administrations of the MeOH extract and TDB significantly delayed the appearance of score 2 skin lesions (local vesicles) and limited the development of further score 6 (mild zosteriform) lesions in infected mice without toxicity compared with controls. In addition, TDB suppressed virus yields in the brain and skin. Therefore TDB should be a promising anti HSV agent.
Similar articles
- Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T, Kurokawa M, Matsuo K, Honda M, Niimura M, Shiraki K. Okuda T, et al. J Med Virol. 2004 Jan;72(1):112-20. doi: 10.1002/jmv.10562. J Med Virol. 2004. PMID: 14635018 - Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo.
Kurokawa M, Hozumi T, Tsurita M, Kadota S, Namba T, Shiraki K. Kurokawa M, et al. J Pharmacol Exp Ther. 2001 Apr;297(1):372-9. J Pharmacol Exp Ther. 2001. PMID: 11259565 - Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM, Rukunga GM, Muli FW, Njagi EN, Njue W, Kumon K, Mungai GM, Muthaura CN, Muli JM, Keter LK, Oishi E, Kofi-Tsekpo MW. Tolo FM, et al. J Ethnopharmacol. 2006 Mar 8;104(1-2):92-9. doi: 10.1016/j.jep.2005.08.053. Epub 2005 Sep 29. J Ethnopharmacol. 2006. PMID: 16198524 - [Development of antiviral therapeutic agents from traditional medicines].
Namba T, Kurokawa M, Kadota S, Shiraki K. Namba T, et al. Yakugaku Zasshi. 1998 Sep;118(9):383-400. doi: 10.1248/yakushi1947.118.9_383. Yakugaku Zasshi. 1998. PMID: 9778999 Review. Japanese. - [Studies on evaluation of natural products for antiviral effects and their applications].
Hayashi T. Hayashi T. Yakugaku Zasshi. 2008 Jan;128(1):61-79. doi: 10.1248/yakushi.128.61. Yakugaku Zasshi. 2008. PMID: 18176057 Review. Japanese.
Cited by
- Evaluating the therapeutic efficacy of triptolide and (S)-10-hydroxycamptothecin on cutaneous and ocular Herpes Simplex Virus type-1 infections in mice.
Aliabadi N, Jamalidoust M, Pouladfar G, Azarpira N, Ziyaeyan A, Ziyaeyan M. Aliabadi N, et al. Heliyon. 2022 Aug 19;8(8):e10348. doi: 10.1016/j.heliyon.2022.e10348. eCollection 2022 Aug. Heliyon. 2022. PMID: 36090228 Free PMC article. - Antimicrobials from Seaweeds for Food Applications.
Cabral EM, Oliveira M, Mondala JRM, Curtin J, Tiwari BK, Garcia-Vaquero M. Cabral EM, et al. Mar Drugs. 2021 Apr 11;19(4):211. doi: 10.3390/md19040211. Mar Drugs. 2021. PMID: 33920329 Free PMC article. Review. - Current landscape in antiviral drug development against herpes simplex virus infections.
Frejborg F, Kalke K, Hukkanen V. Frejborg F, et al. Smart Med. 2022 Dec 16;1(1):e20220004. doi: 10.1002/SMMD.20220004. eCollection 2022 Dec. Smart Med. 2022. PMID: 39188739 Free PMC article. Review. - Review of Whole Plant Extracts With Activity Against Herpes Simplex Viruses In Vitro and In Vivo.
Garber A, Barnard L, Pickrell C. Garber A, et al. J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X20978394. doi: 10.1177/2515690X20978394. J Evid Based Integr Med. 2021. PMID: 33593082 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous